World's first vaccine against deadly swine fever nears approval in Vietnam

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

HANOI: Vaccines against African swine fever being tested in Vietnam are close to approval, global and United States veterinary officials said, in what would be a major breakthrough to tackle the deadly animal disease that regularly

US agriculture secretary Thomas Vilsack said there was likely to be interest in precautionary purchases in the US, despite the country having so far been spared from the virus.

The vaccines were tested in Vietnam, where swine fever is a constant threat, because they could not be developed in the US as the virus is not present there. Currently there are no major outbreaks, but agribusiness lender Rabobank warned in April that the possible spread of the disease, especially in China, remained among the top risks to the global pork industry.United States Department of Agriculture researchers have reviewed the results of one of the vaccines, NAVET-ASFVAC, which they co-developed with Vietnamese company NAVETCO, a USDA spokesperson said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataExperts say mRNA vaccines, paired with drugs that rev up the immune system, may lead to a new generation of cancer therapies. Read more at straitstimes.com.
Source: STForeignDesk - 🏆 4. / 71 Read more »

Cancer vaccines set to unlock 'new treatment paradigm' with Merck/Moderna dataCHICAGO - Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65 per cent over treatment with an immunotherapy alone in a mid-stage trial, the companies reported on Monday (June 5). The results, presented at the American Society of Clinical Oncology meeting in Chicago, follow...
Source: asiaonecom - 🏆 10. / 59 Read more »